Human Papillomavirus

Researchers evaluated the effects of receiving the human papilloma virus vaccine on risk of developing high‐grade cervical intraepithelial neoplasia among 2 cohorts of women born in 1993 and 1983.

The American Cancer Society has released an update to its guidelines for human papillomavirus vaccination, based on recommendations released in 2019 by the ACIP.

Researchers conducted a retrospective matched cohort study involving 132,000 young women in order to evaluate the effects of various dosages of the HPV vaccination on the risk of developing cervical...

The HPV vaccine is recommended for preventing anogenital HPV infections. Now, findings from a recent study suggest the vaccine can provide herd immunity among unvaccinated men against vaccine-type oral HPV...

The new recommendation applies to certain men and women aged 26 years or younger.

HPV is the most common STI around the world, and new research suggests certain forms of the infection may serve as yet another significant risk factor for cardiovascular disease.

The FDA has expanded the age ranges of individuals who may receive the human papillomavirus 9-valent vaccine.

The FDA has expanded the age ranges of individuals who may receive the human papillomavirus 9-valent vaccine.

A recent public health goal set by the American Cancer Society aims to have 80% of adolescents vaccinated against HPV by 2026. But is that achievable?

The authors of a new study aimed to estimate the rate of human papillomavirus vaccine completion among women of various races and ethnicities.